Citation: Ca. Kemper et al., MEXILETINE FOR HIV-INFECTED PATIENTS WITH PAINFUL PERIPHERAL NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TREATMENT TRIAL, Journal of acquired immune deficiency syndromes and human retrovirology, 19(4), 1998, pp. 367-372
Authors:
LALEZARI JP
HOLLAND GN
KRAMER F
MCKINLEY GF
KEMPER CA
IVES DV
NELSON R
HARDY WD
KUPPERMANN BD
NORTHFELT DW
YOULE M
JOHNSON M
LEWIS RA
WEINBERG DV
SIMON GL
WOLITZ RA
RUBY AE
STAGG RJ
JAFFE HS
Citation: Jp. Lalezari et al., RANDOMIZED, CONTROLLED-STUDY OF THE SAFETY AND EFFICACY OF INTRAVENOUS CIDOFOVIR FOR THE TREATMENT OF RELAPSING CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS, Journal of acquired immune deficiency syndromes and human retrovirology, 17(4), 1998, pp. 339-344
Authors:
KEMPER CA
GANGAR M
ARIAS G
KANE C
DERESINSKI SC
Citation: Ca. Kemper et al., THE PREVALENCE OF MEASLES ANTIBODY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS IN NORTHERN CALIFORNIA, The Journal of infectious diseases, 178(4), 1998, pp. 1177-1180
Citation: Ca. Kemper et al., IMMUNOMODULATORY TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN PATIENTS WITH AIDS BY USE OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, The Journal of infectious diseases, 177(4), 1998, pp. 914-920
Authors:
HAVLIR DV
DUBE MP
SATTLER FR
FORTHAL DN
KEMPER CA
DUNNE MW
PARENTI DM
LAVELLE JP
WHITE AC
WITT MD
BOZZETTE SA
MCCUTCHAN JA
Citation: Dv. Havlir et al., PROPHYLAXIS AGAINST DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX WITH WEEKLY AZITHROMYCIN, DAILY RIFABUTIN, OR BOTH (REPRINTED FROM THE NEW-ENGLAND JOURNAL OF MEDICINE, VOL 335, PG 392-398, 1996), Formulary, 32, 1997, pp. 20-28
Citation: Ca. Kemper et al., TRAVELS WITH HIV - THE COMPLIANCE AND HEALTH OF HIV-INFECTED ADULTS WHO TRAVEL, International journal of STD & AIDS, 8(1), 1997, pp. 44-49
Authors:
DUBE MP
SATTLER FR
TORRIANI FJ
SEE D
HAVLIR DV
KEMPER CA
DEZFULI MG
BOZZETTE SA
BARTOK AE
LEEDOM JM
TILLES JG
MCCUTCHAN JA
Citation: Mp. Dube et al., RANDOMIZED EVALUATION OF ETHAMBUTOL FOR PREVENTION OF RELAPSE AND DRUG-RESISTANCE DURING TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA WITH CLARITHROMYCIN-BASED COMBINATION THERAPY, The Journal of infectious diseases, 176(5), 1997, pp. 1225-1232
Citation: Ca. Kemper et Sc. Deresinski, MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN HIV-INFECTION, Bailliere's clinical infectious diseases, 3(1), 1996, pp. 103-122
Authors:
MOHLEBOETANI JC
KOEHLER JE
BERGER TG
LEBOIT PE
KEMPER CA
REINGOLD AL
PLIKAYTIS BD
WENGER JD
TAPPERO JW
Citation: Jc. Mohleboetani et al., BACILLARY ANGIOMATOSIS AND BACILLARY PELIOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - CLINICAL CHARACTERISTICS IN A CASE-CONTROL STUDY, Clinical infectious diseases, 22(5), 1996, pp. 794-800
Authors:
EDWARDS ML
MATT JE
WENSTRUP DL
KEMPER CA
PERSICHETTI RA
MARGOLIN AL
Citation: Ml. Edwards et al., SYNTHESIS AND ENZYMATIC RESOLUTION OF A CARBOCYCLIC ANALOG OF RIBOFURANOSYLAMINE, Organic preparations and procedures international, 28(2), 1996, pp. 193-201
Authors:
HAVLIR DV
DUBE MP
SATTLER FR
FORTHAL DN
KEMPER CA
DUNNE MW
PARENTI DM
LAVELLE JP
WHITE AC
WITT MD
BOZZETTE SA
MCCUTCHAN JA
Citation: Dv. Havlir et al., PROPHYLAXIS AGAINST DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX WITH WEEKLY AZITHROMYCIN, DAILY RIFABUTIN, OR BOTH, The New England journal of medicine, 335(6), 1996, pp. 392-398
Authors:
SISON JP
YAO YZ
KEMPER CA
HAMILTON JR
BRUMMER E
STEVENS DA
DERESINSKI SC
Citation: Jp. Sison et al., TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX INFECTION - DO THE RESULTS OF IN-VITRO SUSCEPTIBILITY TESTS PREDICT THERAPEUTIC OUTCOME IN HUMANS, The Journal of infectious diseases, 173(3), 1996, pp. 677-683
Authors:
SISON JP
YAO YZ
KEMPER CA
HAMILTON JR
DRUMMER E
STEVENS DA
DERESINSKI SC
Citation: Jp. Sison et al., TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX INFECTION - DOES THE BEIGE MOUSE MODEL PREDICT THERAPEUTIC OUTCOME IN HUMANS, The Journal of infectious diseases, 173(3), 1996, pp. 750-753
Authors:
SISON JP
KEMPER CA
LOVELESS M
MCSHANE D
VISVESVARA GS
DERESINSKI SC
Citation: Jp. Sison et al., DISSEMINATED ACANTHAMOEBA INFECTION IN PATIENTS WITH AIDS - CASE-REPORTS AND REVIEW, Clinical infectious diseases, 20(5), 1995, pp. 1207-1216
Citation: Le. Bermudez et al., DYSFUNCTIONAL MONOCYTES FROM A PATIENT WITH DISSEMINATED MYCOBACTERIUM-KANSASII INFECTION ARE ACTIVATED IN-VITRO AND IN-VIVO BY GM-CSF, Biotherapy, 8(2), 1995, pp. 135-142
Authors:
DERESINSKI SC
CLEMONS KV
KEMPER CA
ROESCH K
WALTON B
STEVENS DK
Citation: Sc. Deresinski et al., GENOTYPIC ANALYSIS OF PSEUDOEPIDEMIC DUE TO CONTAMINATION OF HANKS BALANCED SALT SOLUTION WITH CANDIDA-PARAPSILOSIS, Journal of clinical microbiology, 33(8), 1995, pp. 2224-2226
Authors:
ZOLOPA AR
KEMPER CA
SHIBOSKI S
HAMILTON JR
MOSS AR
DERESINSKI SC
Citation: Ar. Zolopa et al., PROGRESSIVE IMMUNODEFICIENCY DUE TO INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS DOES NOT LEAD TO WANING IMMUNITY TO MEASLES IN A COHORT OF HOMOSEXUAL MEN, Clinical infectious diseases, 18(4), 1994, pp. 636-638
Authors:
KEMPER CA
HAVLIR D
BARTOK AE
KANE C
CAMP B
LANE N
DERESINSKI SC
Citation: Ca. Kemper et al., TRANSIENT BACTEREMIA DUE TO MYCOBACTERIUM-AVIUM COMPLEX IN PATIENTS WITH AIDS, The Journal of infectious diseases, 170(2), 1994, pp. 488-493
Authors:
KEMPER CA
HAVLIR D
HAGHIGHAT D
DUBE M
BARTOK AE
SISON JP
YAO YZ
YANGCO B
LEEDOM JM
TILLES JG
MCCUTCHAN JA
DERESINSKI SC
Citation: Ca. Kemper et al., THE INDIVIDUAL MICROBIOLOGIC EFFECT OF 3 ANTIMYCOBACTERIAL AGENTS, CLOFAZIMINE, ETHAMBUTOL, AND RIFAMPIN, ON MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN PATIENTS WITH AIDS, The Journal of infectious diseases, 170(1), 1994, pp. 157-164
Authors:
KEMPER CA
HOSTETLER JS
FOLLANSBEE SE
RUANE P
COVINGTON D
LEONG SS
DERESINSKI SC
STEVENS DA
Citation: Ca. Kemper et al., ULCERATIVE AND PLAQUE-LIKE TRACHEOBRONCHITIS DUE TO INFECTION WITH ASPERGILLUS IN PATIENTS WITH AIDS, Clinical infectious diseases, 17(3), 1993, pp. 344-352
Citation: D. Havlir et al., REPRODUCIBILITY OF LYSIS-CENTRIFUGATION CULTURES FOR QUANTIFICATION OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA, Journal of clinical microbiology, 31(7), 1993, pp. 1794-1798
Authors:
TU SW
KEMPER CA
LANE NM
CARLSON RW
MUSEN MA
Citation: Sw. Tu et al., A METHODOLOGY FOR DETERMINING PATIENTS ELIGIBILITY FOR CLINICAL-TRIALS, Methods of information in medicine, 32(4), 1993, pp. 317-325